SCHEMBL3784717

SCHEMBL3784717

Clc1ccc(Sc2ccccc2)c(Sc2ccccc2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE7A Q13946 3/20 0.59
▸ PDE7B Q9NP56 1/20 0.59
▸ MAPK1 P28482 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ ALDH1A1 P00352 2/20 0.43
▸ HPGD P15428 2/20 0.43
▸ PLA2G1B P04054 1/20 0.43
▸ HSP90AA1 P07900 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ HIF1A Q16665 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ ATG4B Q9Y4P1 1/20 0.43
▸ RHEB Q15382 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6516382 0.92 PDE7A (0.56) PDE7APDE7BMAPK1L3MBTL1MEN1
SCHEMBL28832548 0.88 PDE7A (0.53) PDE7APDE7BMAPK1L3MBTL1MEN1
SCHEMBL9510742 0.85 MEN1 (0.53) PDE7APDE7BMAPK1L3MBTL1MEN1
SCHEMBL10922675 0.84 CYP1A2 (0.50) PDE7APDE7BMAPK1L3MBTL1MEN1
SCHEMBL25177150 0.82 PDE7A (0.54) PDE7APDE7BMAPK1L3MBTL1MEN1
SCHEMBL27955 0.82 PDE7A (0.54) PDE7APDE7BMAPK1L3MBTL1MEN1
SCHEMBL28424052 0.82 PDE7A (0.54) PDE7APDE7BMAPK1L3MBTL1MEN1
SCHEMBL3521485 0.82 PDE7A (0.54) PDE7APDE7BMAPK1L3MBTL1ALDH1A1
SCHEMBL6522399 0.82 PDE7A (0.50) PDE7APDE7BMAPK1L3MBTL1MEN1
SCHEMBL29465671 0.82 PDE7A (0.54) PDE7APDE7BMAPK1L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 — — US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 PDE7A 2371/4885PDE7B 3001/4885MAPK1 4726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback